CCDC132 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.278200E-01
Normal-vs-Stage2
4.050600E-01
Normal-vs-Stage3
2.732400E-02
Normal-vs-Stage4
7.956000E-01
Stage1-vs-Stage2
6.398400E-01
Stage1-vs-Stage3
8.057000E-03
Stage1-vs-Stage4
3.939800E-01
Stage2-vs-Stage3
2.475900E-02
Stage2-vs-Stage4
1.601040E-01
Stage3-vs-Stage4
5.149600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.590400E-01
Normal-vs-AfricanAmerican
5.725000E-01
Normal-vs-Asian
4.601200E-01
Caucasian-vs-AfricanAmerican
9.652200E-01
Caucasian-vs-Asian
5.257400E-01
AfricanAmerican-vs-Asian
7.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.613200E-01
Normal-vs-Female
3.484200E-01
Male-vs-Female
3.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.714600E-01
Normal-vs-Age(41-60Yrs)
7.717600E-01
Normal-vs-Age(61-80Yrs)
3.528000E-01
Normal-vs-Age(81-100Yrs)
4.149400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.121800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.569200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.469200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.705540E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.114200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.506600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.705800E-01
Normal-vs-Daily Drinker
1.581410E-01
Normal-vs-Weekly Drinker
3.366600E-01
Normal-vs-Occasional Drinker
8.699600E-01
Normal-vs-Social Drinker
7.882400E-01
Non Drinker-vs-Daily Drinker
4.605800E-01
Non Drinker-vs-Weekly Drinker
6.609600E-01
Non Drinker-vs-Occasional Drinker
1.928570E-01
Non Drinker-vs-Social Drinker
2.837000E-01
Daily Drinker-vs-Weekly Drinker
8.909800E-01
Daily Drinker-vs-Occasional Drinker
5.870000E-02
Daily Drinker-vs-Social Drinker
8.967600E-02
Weekly Drinker-vs-Occasional Drinker
1.755180E-01
Weekly Drinker-vs-Social Drinker
2.328600E-01
Occasional Drinker-vs-Social Drinker
8.669600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.127840E-01
Normal-vs-Grade 2
6.159100E-03
Normal-vs-Grade 3
1.942450E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.901200E-01
Grade 1-vs-Grade 3
9.306000E-01
Grade 1-vs-Grade 4
1.127840E-01
Grade 2-vs-Grade 3
4.152200E-01
Grade 2-vs-Grade 4
6.159100E-03
Grade 3-vs-Grade 4
1.942450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.537800E-01
Normal-vs-NonDiabetic
3.888800E-01
Diabetic-vs-NonDiabetic
4.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.014800E-01
Normal-vs-NoPancreatitis
3.881200E-01
Pancreatitis-vs-NoPancreatitis
7.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.782400E-01
Normal-vs-N1
4.168800E-01
N0-vs-N1
8.346800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.088000E-01
Normal-vs-TP53-NonMutant
8.663600E-01
TP53-Mutant-vs-TP53-NonMutant
2.361600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
